Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 134, Issue -, Pages -Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2020.111103
Keywords
Cancer; Nanoparticles; Nanotechnology; Targeting therapy; Review
Funding
- National Natural Science Foundation of China [81973908]
- Guangdong Science and Technology Department [2016B030309002, 2019B090905011]
- Fund of Southern Marine Science and Engineering Guangdong Laboratory (Zhanjiang) [ZJW-2019-007]
- Public Service Platform of South China for R&D Marine Biomedicine Resources [GDMUK201808]
- Zhanjiang Science and Technology Plan [2017A06012]
Ask authors/readers for more resources
Nanomedicines provide a promising drug delivery system at the nanoscale to address the targeting and permeability issues of traditional drugs, yet their physical and chemical properties in vivo have not been fully explored. Factors such as metabolic pathways, safety concerns, and in vivo efficacy have prevented many nanomedicines from reaching clinical application.
Nanomedicines offer nanoscale drug delivery system. They offer ways of promising drug transportation, and address the issues of lack of targeting and permeability of traditional drugs. The physical and chemical properties in the domain of nanomedicine applications in vivo have not been sufficiently delivered. What's more, the metabolic of nanomedicines is not clear enough. Those factors which mentioned above determine that many nanomedicines have not yet realized clinical application due to their safety problems and in vivo efficacy. For example, they may cause immune response and cytotoxicity, as well as the ability to clear organs in vivo, the penetration ability of them and the lack of targeting ability may also cause poor efficacy of drugs in vivo. In this review, the new progresses of different kinds of nanomedicines (including gold nanoparticles, nanorobots, black phosphorus nanoparticles, brain diseases, gene editing and immunotherapy etc.) in anti-tumor, antibacterial, ocular diseases and arteriosclerosis in recent years were summarized. Their shortcomings were pointed out, and the new methods to improve the biosafety and efficacy were summarized.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available